FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma.

Gallucci L, Josephine M, Kogure Y, Rosini Silva AA, Cantaloube-Ferrieu V, Souza Abreu ME, Ramteke T, Kibble P, Angelo Braz GLD, Santos Sebastião RA, Lambaz LA, Lin A, Hoare B, Carvalho Dos Santos FC, Shackley S, Quin A, Moelas Giuzio SL, Lewis PA, Zhang W, Nukui Y, Pereira J, Culler HF, Kameda T, Shimoda K, Heesom K, Goldman AR, Sabino EC, Ogawa S, Leal FE, Forcato M, Kataoka K, Garcia Mateos SO, Shytaj IL

Open source

DOI: 10.1038/s44321-026-00535-0
Published: 2026 Nov
Container: EMBO molecular medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s44321-026-00535-0,
  title = {FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma.},
  author = {Gallucci L and Josephine M and Kogure Y and Rosini Silva AA and Cantaloube-Ferrieu V and Souza Abreu ME and Ramteke T and Kibble P and Angelo Braz GLD and Santos Sebastião RA and Lambaz LA and Lin A and Hoare B and Carvalho Dos Santos FC and Shackley S and Quin A and Moelas Giuzio SL and Lewis PA and Zhang W and Nukui Y and Pereira J and Culler HF and Kameda T and Shimoda K and Heesom K and Goldman AR and Sabino EC and Ogawa S and Leal FE and Forcato M and Kataoka K and Garcia Mateos SO and Shytaj IL},
  year = {2026},
  journal = {EMBO molecular medicine},
  doi = {10.1038/s44321-026-00535-0},
  url = {https://doi.org/10.1038/s44321-026-00535-0}
}

RIS

TY  - JOUR
TI  - FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma.
AU  - Gallucci L
AU  - Josephine M
AU  - Kogure Y
AU  - Rosini Silva AA
AU  - Cantaloube-Ferrieu V
AU  - Souza Abreu ME
AU  - Ramteke T
AU  - Kibble P
AU  - Angelo Braz GLD
AU  - Santos Sebastião RA
AU  - Lambaz LA
AU  - Lin A
AU  - Hoare B
AU  - Carvalho Dos Santos FC
AU  - Shackley S
AU  - Quin A
AU  - Moelas Giuzio SL
AU  - Lewis PA
AU  - Zhang W
AU  - Nukui Y
AU  - Pereira J
AU  - Culler HF
AU  - Kameda T
AU  - Shimoda K
AU  - Heesom K
AU  - Goldman AR
AU  - Sabino EC
AU  - Ogawa S
AU  - Leal FE
AU  - Forcato M
AU  - Kataoka K
AU  - Garcia Mateos SO
AU  - Shytaj IL
PY  - 2026
JO  - EMBO molecular medicine
DO  - 10.1038/s44321-026-00535-0
UR  - https://doi.org/10.1038/s44321-026-00535-0
ER  -

APA

L, G., M, J., Y, K., AA, R. S., V, C., ME, S. A., T, R., P, K., GLD, A. B., RA, S. S., LA, L., A, L., B, H., FC, C. D. S., S, S., A, Q., SL, M. G., PA, L., W, Z., Y, N., J, P., HF, C., T, K., K, S., K, H., AR, G., EC, S., S, O., FE, L., M, F., K, K., SO, G. M., & IL, S. (2026). FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma.. EMBO molecular medicine. https://doi.org/10.1038/s44321-026-00535-0

Source records

pubmed · retrieved 2026-11-10T18:59:56.380Z